Teleflex Incorporated (TFX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Teleflex Incorporated stock (TFX) is currently trading at $106.56. Teleflex Incorporated PE ratio is 81.34. Teleflex Incorporated PS ratio (Price-to-Sales) is 2.36. Analyst consensus price target for TFX is $130.50. WallStSmart rates TFX as Moderate Buy.
- TFX PE ratio analysis and historical PE chart
- TFX PS ratio (Price-to-Sales) history and trend
- TFX intrinsic value — DCF, Graham Number, EPV models
- TFX stock price prediction 2025 2026 2027 2028 2029 2030
- TFX fair value vs current price
- TFX insider transactions and insider buying
- Is TFX undervalued or overvalued?
- Teleflex Incorporated financial analysis — revenue, earnings, cash flow
- TFX Piotroski F-Score and Altman Z-Score
- TFX analyst price target and Smart Rating
Teleflex Incorporated
📊 No data available
Try selecting a different time range
TFX Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Teleflex Incorporated (TFX)
TFX trades 74% above its Graham fair value of $61.31, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Teleflex Incorporated (TFX) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, operating margin, price/book. Concerns around return on equity and profit margin. Overall metrics suggest strong investment potential with favorable risk/reward.
Teleflex Incorporated (TFX) Key Strengths (6)
Growing significantly faster than its price suggests
Keeps $41 of every $100 in revenue after operating costs
Earnings per share surging 64.10% year-over-year
108.34% of shares held by major funds and institutions
Trading at 1.49x book value, attractively priced
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Teleflex Incorporated (TFX) Areas to Watch (4)
Company is losing money with a negative profit margin
Very low returns on shareholder equity
Revenue is fairly priced at 2.36x sales
Solid revenue growth at 19.40% per year
Supporting Valuation Data
Teleflex Incorporated (TFX) Detailed Analysis Report
Overall Assessment
This company scores 67/100 in our Smart Analysis, earning a B- grade. Out of 10 metrics analyzed, 6 register as strengths (avg 9.2/10) while 4 fall into concern territory (avg 3.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Operating Margin, EPS Growth. Valuation metrics including PEG Ratio (0.16), Price/Book (1.49) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 40.60%. Growth metrics are encouraging with EPS Growth at 64.10%.
The Bear Case
The primary concerns are Profit Margin, Return on Equity, Price/Sales. Some valuation metrics including Price/Sales (2.36) suggest expensive pricing. Growth concerns include Revenue Growth at 19.40%, which may limit upside. Profitability pressure is visible in Return on Equity at 1.58%, Profit Margin at -45.50%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Profit Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 1.58% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 19.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, Operating Margin) and negatives (Profit Margin, Return on Equity). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
TFX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
TFX's Price-to-Sales ratio of 2.36x sits near its historical average of 2.44x (57th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 63% below its historical high of 6.33x set in Nov 2017, and 228% above its historical low of 0.72x in Mar 2009. Over the past 12 months, the PS ratio has expanded from ~1.7x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for Teleflex Incorporated (TFX) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Teleflex Incorporated is a strong growth company balancing expansion with improving profitability. Revenue reached 2.0B with 19% growth year-over-year. The company is currently unprofitable, posting a -45.5% profit margin.
Key Findings
ROE of 158.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 152M in free cash flow and 152M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -45.5% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Valuation compression risk at a P/E of 81.3x. Any growth miss could trigger a sharp correction.
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Teleflex Incorporated.
Bottom Line
Teleflex Incorporated offers an attractive blend of growth (19% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(25 last 3 months)
| Insider | Type | Shares |
|---|---|---|
RANDLE, STUART A Director, Interim President and CEO | Buy | +12,325 |
Data sourced from SEC Form 4 filings
Last updated: 8:24:22 AM
About Teleflex Incorporated(TFX)
NYSE
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery.